Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock par value $0.001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
7.99M
-
Shares change
-
+7.99M
-
Total reported value, excl. options
-
$81.8M
-
Value change
-
+$81.8M
-
Number of buys
-
43
-
Price
-
$10.49
Significant Holders of Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) as of Q2 2017
43 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock par value $0.001 per share as of Q2 2017.
Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.99M shares
of 134M outstanding shares and own 5.97% of the company stock.
Largest 10 shareholders include FMR LLC (1.81M shares), BlackRock Inc. (1.12M shares), JENNISON ASSOCIATES LLC (650K shares), Tekla Capital Management LLC (536K shares), Redmile Group, LLC (449K shares), OppenheimerFunds, Inc. (425K shares), PRICE T ROWE ASSOCIATES INC /MD/ (362K shares), AMERIPRISE FINANCIAL INC (358K shares), BAKER BROS. ADVISORS LP (333K shares), and SPHERA FUNDS MANAGEMENT LTD. (306K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.